Today: 29 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

SiriusXM (SIRI) Stock Skyrockets 10% After Blowout Q3 Results – What Analysts Are Saying

SiriusXM (SIRI) Stock Skyrockets 10% After Blowout Q3 Results – What Analysts Are Saying

As of Oct 30, 2025, SiriusXM’s stock was trading in the low-$20s. It gapped up 10% on Oct 30 after the earnings releasebenzinga.com, erasing much of the previous month’s decline. Earlier in October the stock had hovered around $21–22, even dipping below $21 on Oct 22stockanalysis.com. Over the 30 days through late October, shares were down about –7.1% compared to a flat S&P 500nasdaq.com. The sudden October rally followed better-than-expected results and raised guidance. Trading volumes spiked on the news, and SIRI closed Oct 30 well above the prior day’s levels. Many observers noted that even after the bounce, SIRI trades at a forward P/E of only ~7–8× – a steep discount to media peersts2.tech. SiriusXM’s third quarter brought a mix of flat top-line and sharply improved profits. Revenue of $2.16 billion was essentially flat year-over-yeard1io3yog0oux5.cloudfront.net, but the company swung from a large loss to a GAAP net income of $297 million, yielding $0.84 in EPSd1io3yog0oux5.cloudfront.net. The huge loss in 3Q2024 reflected a one-time $3.36 billion goodwill impairment from the Liberty Media deal; excluding that, operating results were much better. The adjusted EBITDA for Q3 2025 was $676 milliond1io3yog0oux5.cloudfront.net.
30 October 2025
·
Core Scientific Rises as Bitcoin Booms and CoreWeave Deal Fails, Focus Shifts to AI Data Centers

Core Scientific Rises as Bitcoin Booms and CoreWeave Deal Fails, Focus Shifts to AI Data Centers

Core Scientific’s stock found itself in focus after the dramatic breakdown of a planned merger. On Oct. 30 shareholders rejected CoreWeave’s $9 billion all-stock bidreuters.comdatacenterdynamics.com. Core Scientific said in a press release that it “did not receive the requisite number of votes” and therefore terminated the merger agreement, effective immediatelybusinesswire.com. The result came after weeks of proxy battles: major holder Two Seas Capital led a campaign saying the deal “materially undervalues” Core Scientificreuters.com, and ISS likewise urged a no-vote, reasoning that Core Scientific “has performed well on its own” and can keep growing independentlycoindesk.com. After the vote, CoreWeave CEO Michael Intrator conceded the outcome. He told CNBC that the $9B offer was “a nice to have, not a need to have” and said CoreWeave would not sweeten its bidcoindesk.com. In a public statement, Intrator said “we respect the views of Core Scientific stockholders and look forward to continuing our commercial partnership”datacenterdynamics.com, emphasizing that CoreWeave’s cloud/data strategy remains unchanged. Core Scientific’s management welcomed the clarity. CEO Adam Sullivan reiterated that the company is focused on its own path. “We intend to continue to transform and expand our hosting business and our earnings power as we provide valuable capacity to the dynamic
30 October 2025
··
Critical Metals (CRML) Stock Skyrockets on Rare-Earth Boom – What’s Next?

Critical Metals (CRML) Stock Skyrockets on Rare-Earth Boom – What’s Next?

CRML’s chart over the past month has been extreme. In the week after U.S. stake rumors the stock vaulted from about $10 to ~$16.60ts2.tech, then briefly spiked to an intraday high of $21.45 on Oct. 13ts2.techts2.tech. Trading volumes surged, underlining the volatility. Technical analysts at StocksToTrade noted CRML “traded as low as $10.20 and as high as $16.98 in just one week”ts2.tech. After the mid-month profit-takingfxleaders.com, the stock stabilized near its 50-day moving average. On Oct. 30 CRML is trading around $13.5reuters.com, well above its late-Sept level but below the mid-month peak. Market analysts caution that such wild swings are likely to continue, given the speculative nature of the storyts2.tech. CRML has been in the headlines nearly every day. The biggest catalyst was the U.S. rare-earth gambit: on Oct. 6 Reuters reported that Trump administration officials were discussing taking an 8% stake in CRMLts2.techts2.tech. This news alone sent CRML soaring and was cited by Benchmark Mineral Intelligence’s Neha Mukherjee as a move toward “a diversified ‘mine-to-magnet’ supply chain independent of China”reuters.com. The White House quickly noted the talks were preliminary, but the buzz lifted the stock to record highs.
30 October 2025
·
EMCOR Group (EME) Delivers Record Q3 – So Why Are Shares Crashing?

EMCOR Group (EME) Delivers Record Q3 – So Why Are Shares Crashing?

EMCOR’s Oct 30 report painted an overwhelmingly positive picture: “We had an outstanding third quarter,” CEO Tony Guzzi told analystsbusinesswire.com, noting 16.4% revenue growth and an all-time high backlog. Net income was $295.4Mbusinesswire.com, well above last year’s $270.3M. In fact, EMCOR narrowly beat the street’s EPS consensusnasdaq.com – though it fell slightly below a higher Zacks estimate of $6.65timesunion.com. The full-year outlook was boosted: revenues now expected ~$16.75 B with EPS at least $25.00businesswire.comnasdaq.com. Guzzi highlighted that performance obligations jumped to $12.61Bbusinesswire.com, and said the company’s diverse pipeline supports a “positive outlook for the rest of the year”businesswire.com. Despite the strong quarter, EME shares tumbled after the news. On Oct 30, the stock gapped down about 10% and closed near $645, roughly 17% below the prior closefinviz.com. In the days leading up to earnings, EME had been on a tear – up roughly 15% over Oct. 23–24 and more than doubling from its 52-week lowstockanalysis.comfinviz.com. The sudden selloff likely reflects profit-taking and a high bar: by late October EME was trading just above analysts’ 12-month consensus targetts2.tech, suggesting valuation concerns. A Zacks note pointed out that with the stock already up +71% YTDnasdaq.com, some pullback could have been expected.
30 October 2025
··
Navan’s $6.5B IPO Set for Takeoff – TravelTech Unicorn Aims High, But Will It Deliver?

Navan’s IPO Flop? TravelTech Stock Sinks 12% on Nasdaq Debut

Navan’s first day as a public company was rocky. The stock debuted on Nasdaq under the ticker NAVN, immediately trading below its IPO price. Reuters reports Navan “started trading 12% below” the offering price, opening around $22reuters.com. By midday on Oct 30 the stock was near $21.14, a ~15% drop from $25investing.com. This initial slide wiped out tens of millions in paper value – the company’s fully diluted market cap dipped to about $5.9–6.7 billionreuters.com. Some insiders put a positive spin on the debut’s rough start. CEO Ariel Cohen remained upbeat, highlighting Navan’s AI-driven edge. Cohen told Reuters, “We see ourselves as an AI-first company” – noting Navan’s tools can cut clients’ travel costs by roughly 15%reuters.com. CFO Amy Butte echoed the AI focus: “We actually demonstrate our use of AI in our numbers,” she said, pointing out that AI features have helped expand Navan’s profit marginsreuters.com. These comments underscore the company’s pitch that its technology gives Navan a competitive lead in the corporate travel sector.
30 October 2025
··
Salesforce Stock Soars After Dreamforce AI Bombshell – What Investors Need to Know (Oct. 21, 2025)

Salesforce (CRM) Stock Rockets After $60B Dreamforce AI Bombshell – Can the Rally Last?

Salesforce’s shares have been on a bumpy ride. After hitting a low around $235.69 on Oct. 1ts2.tech, CRM stabilized in the mid-$230s. The big story came mid-October at Dreamforce, when management rolled out its ambitious plans. The $60B by 2030 revenue projection sparked a market rally: in after-hours trading on Oct. 15, CRM jumped about 5%ts2.techts2.tech. By Oct. 16’s close, the stock was trading in the mid-$240s. “We have had some lower-stage growth for a while… that is reaccelerating,” said CFO Robin Washington at Dreamforcets2.tech – a signal intended to reassure shareholders about a growth rebound. At the same time, broader tech trends are influencing CRM’s moves. October brought a surge in AI-related stocks on renewed AI optimismts2.tech. Salesforce has leapt on that bandwagon with new AI partnerships and product launches. However, investors remain sensitive to economic headwinds. A cybersecurity scare in early October added caution. Salesforce insists its own cloud was not breachedts2.tech, but the incident was a reminder of data risks in the cloud era.
30 October 2025
··
IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?

AI & Quantum Sparks a Big Blue Comeback – IBM Stock Rallies (But Will it Last?)

Image: The IBM logo has been prominently displayed at tech conferences as Big Blue pushes its new AI/cloud and quantum initiatives. Valuation & Dividends: IBM now trades at tech-like multiples – forward P/E in the mid-20sts2.tech, well above its historical ~16×. The company boasts strong cash flow and a dividend yielding ~2.3%ts2.techts2.tech. IBM is a Dividend Aristocrat with 29 years of consecutive raisests2.tech, which helps cushion concerns over valuation.
30 October 2025
·······
Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon (AMZN) Stock Skyrockets: Q3 Beats, Cloud Boom & $2.5B FTC Win

Sources: Contemporary news and analysis, including Reutersreuters.comreuters.comreuters.comreuters.com, company guidance and press releases, as well as reports from CNBC, Bloomberg, MarketWatch, MarketBeat, and tech analysists2.techftc.govbusinessinsider.comts2.tech, among others. All quotes and data points are drawn from the cited sources.
30 October 2025
·
SAP Stock Skyrockets on Cloud Boom – Analysts Eye New Highs?

SAP Stock Soars on Cloud Surge — Can the Rally Continue?

*Source: Stockanalysis.comstockanalysis.com. Bottom Line: SAP remains a market heavyweight riding a powerful transition to cloud and AI. Its Q3 results showed solid gains, but management warned of a near-term slowdown in cloud growth. Analysts say the long-term story is positive – backlog is large and costs are in check – but with the stock near cycle highs, “the rally” may need new catalysts to keep climbing. Investors will be watching upcoming earnings and how well SAP turns its AI/cloud investments into sales.
30 October 2025
··
China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

China and Russia have upped their economic partnership with a new set of agreements. In late October 2025 Beijing and Moscow announced that they would “push for a stable expansion of two-way trade with an optimized structure”en.people.cn. Commerce Minister Wang Wentao and Russia’s economic minister Reshetnikov co‑chaired a subcommittee meeting on Sept. 28, where they agreed to deepen cooperation in areas from digital services to infrastructure. Most notably, President Putin signed the law ratifying an updated Bilateral Investment Treaty with Chinarussiaspivottoasia.com. This overhaul — originally agreed in May — strengthens legal protections for investors and introduces “single-window” support and visa facilitation for businesspeople, addressing hurdles that had stalled cooperation. The new agreement formally extends the “Power of Siberia 2” gas pipeline project. Gazprom CEO Alexei Miller confirmed that a “legally binding memorandum” was signed during Putin’s September visit, kicking off construction of the pipeline through Mongoliareuters.com. Industry analysts at the Oxford Institute project that even with a final deal, first gas deliveries might not occur before 2030, with full ramp-up by mid-2030sreuters.comreuters.com. In parallel, Russia is expanding LNG supply to Chinareuters.com. The overall aim is to diversify Russia’s markets beyond Europe and to secure China’s access to energy and raw
30 October 2025
····
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle’s stock peaked at an all-time high around $345 in early Sept. 2025 thanks to blockbuster AI/cloud news ts2.tech. In the past two weeks it has pulled back to the high-$200s: on Oct. 24 it traded in the $282–$287 range ts2.tech, but by Oct. 30 it was around $270. This recent drop followed a very sharp run-up – ORCL fell about 7% on Oct. 17 after Oracle issued extremely aggressive multi-year forecasts at its AI World event ts2.tech ts2.tech. Technicals show ORCL bouncing off its 50-day moving average near $274 ts2.tech. Over the year the uptrend is clear: ORCL was near $160 in Jan. 2025 and even with the Oct. pullback it’s still far above that. TS2’s analysis noted that in 2025 “even after recent declines, ORCL remains up dramatically” YTD ts2.tech. In short-term terms, analysts see the chart as volatile but upward-biased amid newsflow. On Sept. 9, Oracle reported fiscal Q1 2026 results that largely met expectations. Total revenue was $14.93 billion, +12% YoY ts2.tech. Cloud revenues jumped 28% to $7.2B ts2.tech, driven by strong growth in OCI and steady SaaS. Non-GAAP EPS was $1.47 ts2.tech. The company noted software license revenue dipped slightly. Management highlighted the massive sales
30 October 2025
···
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Rockets to $5 Trillion Valuation – AI Frenzy Fuels Record Highs

Nvidia’s Santa Clara campus. The company’s stock hit record highs this week as AI chip demand exploded, powering Nvidia to a historic $5 trillion market valuereuters.comreuters.com. Nvidia shares extended a remarkable run this week. On Oct 29, the stock closed at about $207.04, up ~3% on the day, pushing its market capitalization to $5.03 trillionreuters.com. This made Nvidia the first public company ever to exceed $5 trillion in valuereuters.com. By the next trading session, NVDA hovered around $204–$205reuters.com, a slight pullback in a broadly record-setting market. Over 2025 so far, NVDA’s stock is up roughly 50%reuters.com, dramatically outperforming indices. For context, since the launch of ChatGPT in late 2022, Nvidia shares have climbed over 10-foldreuters.com.
30 October 2025
···
Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

BYD’s October 2025 report shocked investors: third-quarter profit plunged to ¥7.8 billion, down almost 33% from a year agode.investing.com. CEO Wang Chuanfu has slashed prices across BYD’s model range to fend off competition, triggering the rare profit drop. Analysts say this reflects Beijing’s crackdown on extreme discounting in China’s overheated EV marketts2.techts2.tech. Despite the revenue hit, BYD remains China’s sales leader: its 1H 2025 revenue exceeded Tesla’s for the first timets2.tech, illustrating its massive volume advantage. However, BYD’s aggressive pricing “strategy” now worries investors. As one market analyst notes, there is “real concern around BYD’s aggressive ‘market share gain by pricing’ strategy… in the short term, this should weigh on margins”ts2.tech. Indeed, BYD cut its 2025 sales target from 5.5 million to 4.6 million vehiclests2.techts2.tech, acknowledging that the China price war will damp growth.
30 October 2025
·
Tesla’s Trillion-Dollar Gamble: Musk’s Epic Pay Deal Divides Investors – What You Need to Know

Tesla Stock Surges on Record Q3 Sales – Can It Keep Climbing?

Tesla Inc. shares have been trading near the top of their 52-week range amid the late-October market rally. After rising to new highs earlier in October, the stock consolidated in the low- to mid-$440s by Oct. 30ts2.techts2.tech. On Monday Oct. 27, TSLA jumped about 4.3% – its largest one-day gain in weeks – on news of improving U.S.–China trade talks and continued buzz around its technology roadmapts2.tech. By that day’s close the stock was trading near $449, and it remained in the high $440s by late Oct. 29ts2.techstockanalysis.com. Year-to-date the shares are up roughly 10–12%, and about 80% above levels of a year agots2.tech. Broader market moves have influenced TSLA. In late October the S&P 500 was under modest pressure from concerns about interest rates and economic growth, but hopes that the Federal Reserve may cut rates by year-end have helped high-growth tech names like Teslats2.tech. At the same time, any setbacks in U.S.–China relations remain a wildcard. In fact, Reuters reported that even a reported call arranged between President Trump and Elon Musk was cited as a catalyst for the Oct. 27 rallyts2.tech. In short, Tesla’s volatility has mirrored major themes – it rallies on news of new products
30 October 2025
···
BYD’s European EV Invasion – Boom in Sales but Stock Takes a Hit

BYD Stock Plunges 30% on Profit Slump – Is the EV Price War to Blame?

BYD’s stock has experienced a sharp correction in recent months. In early 2025 the Hong Kong-listed shares hit record highs, but by late October they traded near HK$104reuters.com – roughly 30% below the peakbloomberg.com. This slide erased tens of billions in market value. For example, Bloomberg reports the company lost over $45 billion of market cap as stock slid 32% from May to Octoberbloomberg.com. Investors have blamed weaker-than-expected earnings and slowing growth in China. On Oct. 29, trading ahead of the earnings release, BYD’s Hong Kong shares rose slightlyreuters.com as some traders hoped for a rebound. But by Oct. 30, after news of the large profit drop, sentiment soured. Over the past few weeks the stock actually marked its fifth straight month of losses, the longest streak since 2018bloomberg.com. Even so, analysts note that price targets remain far above current levelsts2.tech, suggesting many see the pullback as overdone.
30 October 2025
··
Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Metsera’s share price has been on a roller-coaster amid takeover speculation. In late September, Pfizer agreed to buy Metsera for $47.50 per share in cash plus up to $22.50 in contingent paymentssec.gov. Pfizer CEO Albert Bourla said this deal “propels Pfizer into this key therapeutic area” of obesity treatmentsec.gov. Metsera CEO Whit Bernard called the deal “an excellent outcome for our shareholders” and praised the chance to “realize the promise of improved human health at scale” under Pfizer’s wingsec.gov. On Oct. 30, Novo Nordisk dramatically entered the fray with an unsolicited offer valuing Metsera at up to $9 billion. Novo’s proposal is $56.50 per share cash at signing plus up to $21.25 in contingent value rightsprnewswire.com. The Metsera board declared Novo’s bid a “Superior Company Proposal”, triggering a four-day window for Pfizer to respondprnewswire.com. Pfizer immediately denounced the move: a Pfizer press release called Novo’s bid “reckless” and warned it could “suppress competition” in obesity drugsmarkets.ft.com.
30 October 2025
····
Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Inc. is a leading neuroscience biotech known for multiple sclerosis and rare-disease therapiests2.tech. On Oct. 30, 2025 the stock dipped after a mixed earnings release. The company beat Q3 expectations – adjusted EPS $4.81 vs. $3.88 est and $2.53 B revenue vs. $2.34 B estng.investing.com – but lowered its full-year outlook. Biogen now expects 2025 non-GAAP EPS of $14.50–$15.00, citing an anticipated ~$1.25 per-share charge in Q4 for recent R&D dealsreuters.comreuters.com. CEO Chris Viehbacher spun the quarter positively, noting “we delivered another quarter of strong financial performance driven by … momentum in our launch products [and] resilience in our MS franchise”ng.investing.com. Indeed, Biogen’s newer products performed well: Alzheimer’s treatment Leqembi saw global sales of about $121 Mreuters.com and rare-disease drugs like Skyclarys and Zurzuvue continue to growsec.gov. However, Biogen’s core multiple sclerosis line held nearly flat as U.S. demand for Vumerity rose but Tecfidera declined overseasng.investing.com.
30 October 2025
··
GLE Stock Skyrockets 50%: Key Facts & What’s Next

GLE Stock Skyrockets 50%: Key Facts & What’s Next

Market context: Hong Kong’s stock market has been booming in 2025ts2.tech. GLE’s recent spike comes against a broad tech rally, but its own financials remain thin. In late Oct 2025, GLE’s stock was trading in the $0.62–0.70 rangestockanalysis.com. On Oct 29 it closed at $0.6526stockanalysis.com, which was already a rebound from earlier October levels. Suddenly after the market closed, the price jumped by over 40% to about $0.92stockanalysis.com. By early Oct 30 it hit roughly $0.995stocktitan.net. Trading volume spiked. No official announcement accompanied the move, so it appears driven by speculative trading or rumors. Overall, GLE’s stock has been volatile: after surging as high as the mid-$1s in September, it slid back to the $0.60s in early Octoberstockanalysis.comstockanalysis.com.
30 October 2025
·
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna’s stock has pulled back modestly in late October after a strong run earlier in the year. According to market data, CI closed at $299.12 on Oct 29, 2025, down about 3% from the previous closestockanalysis.com. The dip followed weakness in broader managed-care stocks amid concerns about healthcare costs and policy. In pre-market trading Oct 30, CI rebounded to about $303reuters.com. Over the past year, CI shares have traded between roughly $257 and $350stockanalysis.com, reflecting volatility in the insurance sector. Despite the pullback, Cigna’s valuation metrics remain attractive: at ~16x forward earnings, it still trades well below historical levels. Analysts note that a year-long surge left CI ripe for profit-taking. As Morningstar’s Julie Utterback observed, Cigna “maintained the status quo from a 2025 guidance perspective, which is probably what is keeping shares flat”reuters.com. In other words, the company stuck to its outlook, so the stock is trading largely on fundamentals rather than any new surprises.
30 October 2025
···
1 … 234 235 236 237 238 … 396
Go toTop